The study of AIM2 in different liver diseases (Table 1) is supported by the fact that inflammation, either sterile (e.g., NAFLD and NASH) or induced by pathogens (e.g., viral hepatitis), is the origin of most of these diseases. Here, AIM2 is linked to metabolic dysfunction-associated steatotic liver disease.